{"nctId":"NCT01014390","briefTitle":"WallFlex Biliary Fully Covered (FC) Benign Stricture Study","startDateStruct":{"date":"2009-12","type":"ACTUAL"},"conditions":["Biliary Stricture"],"count":187,"armGroups":[{"label":"WallFlex Biliary RX FC Stent System","type":"EXPERIMENTAL","interventionNames":["Device: WallFlex Biliary RX Fully Covered Stent System"]}],"interventions":[{"name":"WallFlex Biliary RX Fully Covered Stent System","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 or older\n* Willing and able to comply with the study procedures and provide written informed consent to participate in the study\n* Chronic pancreatitis or prior liver transplantation or prior other abdominal surgery (to include cholecystectomy)\n* Indicated for ERCP procedure with stent placement for: Symptomatic bile duct stricture (i.e. obstructive jaundice, persistent cholestasis, acute cholangitis) confirmed by cholangiogram and/or Bile duct stricture confirmed by cholangiogram and/or Exchange of prior plastic stent(s) for management of benign stricture\n\nExclusion Criteria:\n\nGeneral:\n\n* Placement of the stent in strictures that cannot be dilated enough to pass the delivery system\n* Placement of the stent in a perforated duct\n* Placement of the stent in very small intrahepatic ducts\n* Patients for whom endoscopic techniques are contraindicated\n* Biliary stricture of malignant etiology\n* Biliary stricture of benign etiology other than chronic pancreatitis or liver transplant anastomosis or other abdominal surgery\n* Stricture within 2 cm of duct bifurcation\n* Symptomatic duodenal stenosis (with gastric stasis)\n* Prior biliary self-expanding metal stent\n* Suspected stricture ischemia based on imaging of hepatic artery occlusion or endoscopic evidence of biliary cast syndrome\n* Known bile duct fistula\n* Known sensitivity to any components of the stent or delivery system\n* Participation in another investigational study within 90 days prior to consent or during the study\n\nAdditional Specific to Chronic Pancreatitis Patients:\n\n* Developing obstructive biliary symptoms associated with an attack of acute pancreatitis\n\nAdditional Specific to Post-Abdominal Surgery Patients:\n\n* History of hepatectomy\n* History of liver transplant\n\nAdditional Specific to Liver Transplant Patients:\n\n* Live donor transplantation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Stent Removability","description":"Defined as ability to remove the stent endoscopically without serious stent removal related adverse events as assessed from the time of stent removal to 1month post-stent removal.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"132","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":51,"n":187},"commonTop":[]}}}